Chinese Biotechs Raise New Funds On Potential First-In-Class Assets

 
• By Dexter Jie Yan
  
funding
Chinese biotechs spearheading the development of first-in-class therapies have secured new modest-sized funding rounds • Source: Shutterstock

More from Financing

More from Business